Skip to search boxSkip to navigationSkip to main content

Impact of non-genetic factors on severe cutaneous adverse reactions and associated mortality in ESRD patients: Advancing clinical guidance

*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

<p>Background: In end-stage renal disease (ESRD), reduced renal function affects medication response and clearance, increasing risk of adverse drug reactions. Renal disease is a risk factor for poor prognosis in severe cutaneous adverse reactions (SCARs). The effects of SCARs in ESRD patients are less understood. Methods: This retrospective analysis of the United States Renal Data System (USRDS) evaluated whether SCARs are an independent risk factor for mortality in ESRD patients, controlling for demographic and clinical factors, including malnutrition, sepsis, pneumonia, secondary autoimmune conditions and Charlson Comorbidity Index (CCI). We examined whether Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) or drug reaction with eosinophilia and systemic symptoms (DRESS) was associated with all-cause mortality in subjects enrolled in the USRDS from 2005 to 2018. Results: Patients with DRESS were more often female (OR = 1.37), with catheter (OR = 1.08) or graft (OR = = 1.15) access and a higher CCI (OR = 1.21). Those with SJS/TEN were more likely to be black (OR = 2.43) or other race (OR = 2.06) and female (OR = 1.55), with catheter access (OR = 1.36) and a higher CCI (OR = 1.18). DRESS and SJS/TEN were associated with higher risk of malnutrition (OR = 1.64, OR = 2.61), sepsis (OR = 1.93, OR = 3.38), pneumonia (OR = 1.82, OR = 1.80), and secondary autoimmune conditions (OR = 1.47, OR = 1.47). Patients with DRESS (HR = 2.05) or SJS/TEN (HR = 3.12) had increased mortality across 12 months following diagnosis. Increasing age (HR = 1.04), hemodialysis (HR = 1.76), catheter (HR = 2.58) or graft (HR = 1.52) access, malnutrition (HR = 1.07), and sepsis (HR = 1.26) increased mortality risk. Conclusion: ESRD patients' risk for SCARs varied by age, race, sex, comorbidities, and dialysis modality. Patients with a SCAR had increased mortality across 12 months following diagnosis.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 613-619 (7 pages)

Journal (Volume, Issue Number)

American Journal of the Medical Sciences (Volume 369, Issue 5)

Publication milestones

  • Accepted/In press - 2025
  • Published - 05/2025

Publication status

Published - 05/2025

ISSN

0002-9629

Publication IDs

  • Scopus: 86000510758
  • PubMed: 39952290
  • ORCID: /0000-0003-3146-162X/work/183593088

Publication metrics

Metrics

Fractional count
3
Fractional count
0.60
Fractional count
2
Fractional count
0.40
Fractional count
3
Fractional count
1

PlumX, opens in new tab

Citation count
1
Captures
3

Funding Details

This work was supported in part by the Translational Research Program of the Augusta University Department of Medicine. W.B.B. is supported by a VA Research Career Scientist Award (#IK6 BX005691), and S.L.B.’s research effort is supported by the VA Augusta Healthcare System.
FundersFunding number
Augusta University Department of Medicine
-
VA Augusta Healthcare System
-
VA Research
#IK6 BX005691